NYSE · Financial Statements
GSK plc (GSK) Financial Statements
$51.58
NYSE: GSK
Market Cap $103.73B
Overview Financials Dividend GSK plc most recently reported annual revenue of $32.7B, net profit of $5.7B, revenue has compounded at 6.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $24.7B $29.3B $30.3B $31.4B $32.7B Operating Profit $4.4B $6.4B $6.7B $4.0B $8.3B Net Profit $4.4B $15.0B $4.9B $2.6B $5.7B EPS $2.70 $2.40 $2.40 $1.24 $5.56 Op Margin 17.6% 21.9% 22.2% 12.8% 25.5%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $107.1B $60.1B $75.2B $59.5B $61.0B Total Liabilities $78.2B $50.0B $58.9B $46.4B $45.0B Cash $5.8B $3.7B $3.7B $3.7B $3.4B Borrowings $32.7B $21.0B $23.0B $17.0B $17.7B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $8.0B $8.2B $7.9B $6.6B $7.1B Investing Cash Flow $-4.4B $-12.3B $-4.0B $-4.2B $-7.0B Financing Cash Flow $-1.6B $12.0B $-342.0M $-1.1B $-573.0M Net Cash Flow $-1.4B $-1.3B $-736.0M $545.0M $-206.0M Free Cash Flow $5.3B $6.8B $6.3B $3.6B $5.8B
Valuation & Return Ratios
Metric Value PEG Ratio — EV / EBITDA 11.08 FCF Yield 6.56% Quick Ratio 0.52 Interest Coverage 12.14 Return 1Y 33.42% Return 3Y 60.85% Return 5Y 61.70%
Screens featuring this stock